Royal Bank of Canada’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Royal Bank of Canada’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,084	Closed	–	–	7945
2023 Q2	$0	Sell	1,084 -4,894	-82%	-$1.48K	﹤0.01%	7902
2023 Q1	$2K	Sell	5,978 -8,901	-60%	-$6.83K	﹤0.01%	6839
2022 Q4	$18K	Buy	14,879 +11,800	+383%	+$19.2K	﹤0.01%	6356
2022 Q3	$7K	Buy	3,079 +3,001	+3,847%	+$7.86K	﹤0.01%	6633
2022 Q2	$0	Sell	78 -1,995	-96%	-$13.8K	﹤0.01%	7963
2022 Q1	$20K	Buy	+2,073	New	+$18.6K	﹤0.01%	6618

Royal Bank of Canada's GRNA Position: Q3 2023 in Review

Royal Bank of Canada sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 1,084 shares.

Royal Bank of Canada first reported a position in GRNA in Q1 2022 and held it in 6 quarters. The position peaked at $20K in Q1 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Royal Bank of Canada reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Royal Bank of Canada sold 1,084 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023.
Royal Bank of Canada first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2022 and held it in 6 quarters.
Royal Bank of Canada's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $20K in Q1 2022.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.